{"version":"1.0","provider_name":"Najafi Capital Deal Making Platform","provider_url":"https:\/\/najafi.capital\/pl","author_name":"admin","author_url":"https:\/\/najafi.capital\/pl\/author\/admin\/","title":"Investment Partner, Individual\/Angel: Philip Reilly - Najafi Capital Deal Making Platform","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"lTnWnaSha4\"><a href=\"https:\/\/najafi.capital\/pl\/individual-investor\/investment-partner-individual-angel-philip-reilly\/\">#ERROR!<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/najafi.capital\/pl\/individual-investor\/investment-partner-individual-angel-philip-reilly\/embed\/#?secret=lTnWnaSha4\" width=\"600\" height=\"338\" title=\"&#8222;Investment Partner, Individual\/Angel: Philip Reilly&#8221; &#8212; Najafi Capital Deal Making Platform\" data-secret=\"lTnWnaSha4\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/najafi.capital\/wp-includes\/js\/wp-embed.min.js\n<\/script>","description":"Philip Reilly is our Interim Chief Medical Officer and a Venture Partner at Third Rock Ventures. He is a highly respected clinical geneticist with an extensive track record in launching and building companies that seek to develop new therapies for rare genetic disorders. Dr. Reilly joined Third Rock in 2008 to focus on discovering, launching [&hellip;]"}